# V1 Empirics Check — openai/gpt-5.1-codex-mini (Variant A)

**Model:** openai/gpt-5.1-codex-mini
**Variant:** A
**Date:** 2026-03-27T14:43:25.639679

---

**Idea Fidelity**

The paper largely tracks the original idea. It exploits the staggered rollout of conversion therapy bans across 22 states (origin text mentioned 24 states plus DC, but here the sample covers 22 states appearing in the YRBSS data) and the YRBSS microdata to assess impacts on multiple adolescent mental health outcomes. The empirical strategy is a TWFE difference-in-differences, with a heterogeneity analysis by sexual identity mirroring the proposed triple-difference. The manifest’s emphasis on broader outcome vectors, the richer post period (including 2021 and 2023), and the focus on destigmatization are all reflected. One divergence is that the sexual identity heterogeneity estimation uses only two waves (2021, 2023) and hence relies on cross-state variation rather than within-state pre-post changes; the manifest had hoped for a triple-difference leveraging staggered timing, which is only partially realized.

---

**Summary**

This paper evaluates whether state conversion therapy bans for minors causally improve adolescent mental health using staggered adoption across 22 states and individual-level YRBSS data from 2015–2023. TWFE difference-in-differences estimates show significant reductions in persistent sadness and suicide planning for the general adolescent population, while the LGB-only sample (from 2021–2023) experiences much larger declines in suicidality, consistent with the bans delivering a “destigmatization dividend.” Robustness checks include placebo outcomes, leave-one-out analyses, and Callaway–Sant’Anna estimates, and the paper situates the effects in terms of signaling versus direct protection mechanisms.

---

**Essential Points**

1. **Parallel trends and event-study evidence need to be presented in the main text.** The credibility of the staggered DiD hinges on showing that treated and control state outcomes moved in parallel before adoption. The paper mentions an event study, but no coefficients, figures, or tables are provided, nor are the placebo tests elaborated beyond a short paragraph. Without these, readers cannot assess whether pre-trends or anticipatory effects threaten identification. Please display the event-study coefficients (or summarized Pre-treatment averages) for each main outcome, ideally with confidence intervals, and discuss whether any leads are statistically different from zero.

2. **State-level time-varying confounders require further control.** Conversion therapy bans likely correlate with broader pro-LGBTQ+ policy environments (e.g., non-discrimination laws, school anti-bullying policies, Medicaid expansion) or secular shifts in public opinion that also influence youth mental health. The paper mentions adjusting for “state political composition” and “other LGBTQ+ laws” in the manifest, but there is no details in the main text or tables. Please document which state-level controls are included, how they are timed relative to the ban (contemporaneous or lagged), and whether results are robust to including state-specific linear trends or recent political shifts (e.g., gubernatorial party). Without this, the ban indicator could simply proxy for a broader policy package.

3. **The sexual identity heterogeneity estimates are identification-challenged.** Because the sexual identity question only exists in 2021 and 2023, the Ban × LGB interaction and the separate LGB subsample estimates rely purely on cross-state comparisons during those two waves. Any unobserved state-level factor that (a) coincides with ban adoption during this period and (b) differentially affects LGB youth—such as targeted school supports or local advocacy—could bias the estimates. More discussion of this limitation is needed, along with empirical checks (e.g., adding interactions between state fixed effects and year dummies, controlling for contemporaneous state-level policies, or instrumenting for bans if feasible). At minimum, the paper should better justify why the cross-sectional comparison still plausibly identifies the differential effect.

If more than these three points need addressing, reject.

---

**Suggestions**

- **Report event-study graphs and pre-trend tests explicitly.** Beyond just stating that there are “no pre-trends,” include figures in the main text (or appendix) showing the Ban indicator’s leads and lags for each outcome. Show the number of pre-treatment periods used, and test joint significance of leads. This enhances transparency and allows readers to judge the credibility of the parallel-trends assumption.

- **Explicitly describe and justify the state-level control strategy.** The manifest mentions political composition and other LGBTQ+ laws; the paper should list these controls (e.g., percent Democratic legislature, existence of same-sex marriage recognition, non-discrimination statutes) and clarify whether they are lagged or contemporaneous to avoid “bad control” concerns. Consider adding state-by-year controls for economic conditions (unemployment, income) that may influence adolescent distress. Reporting whether the inclusion of these controls meaningfully changes coefficients will bolster confidence that the Ban variable captures the policy effect rather than correlated unobservables.

- **Consider state-specific trends and alternative weighting.** Adding state-specific linear trends (or spline trends) can mitigate concerns that treated states were already on different trajectories. Alternatively, estimate the main DiD using weighted FE that gives more weight to states with better pre-treatment fit (e.g., synthetic control-inspired). If state-specific trends are too aggressive, show they do not materially alter your conclusions.

- **Engage more deeply with Callaway–Sant’Anna results.** The CS ATT estimates are much smaller and imprecise than the TWFE results, and this deserves interpretation. Report group-time ATTs (e.g., for first-treated vs. later-treated states) to see whether effects are concentrated in early adopters, and whether the TWFE results could be driven by states with limited controls. Explain whether the smaller CS estimates reflect attenuation due to aggregation or a sign of treatment effect heterogeneity that TWFE misweights. If possible, present leads/lags derived from CS for comparison.

- **Clarify the mechanism narrative with empirical proxies.** The destigmatization argument is compelling, but could be strengthened with indirect evidence. For example, explore whether parental discrimination concerns or self-reported school climate improved after bans (if YRBSS includes relevant questions) or whether changes occur predominantly in states where the bans were accompanied by high-profile media coverage. Alternatively, correlate ban adoption with proxies for social acceptance (e.g., Google search intensity or Pride events) to show signaling plausibility.

- **Address potential sample selection due to state participation.** The YRBSS is not perfectly balanced across states and years; some ban states may appear only after adoption, while some never participate. Provide a table listing the sample states by adoption year and participation to reassure readers that the comparison group is valid. If certain early- or late-adopting states are missing, discuss how that might bias the estimated effects.

- **Provide more detail on the sexual identity question.** Explain the exact wording, response rates, and whether the question was administered consistently across ban and no-ban states in 2021/2023. If there is differential non-response or item missingness, address how that could bias the heterogeneity results. You may consider inverse probability weighting or multiple imputation if missingness is non-random.

- **Discuss the generalizability of the effect sizes.** The back-of-envelope calculation on avoided suicide attempts is helpful, but it assumes the sample is nationally representative of all LGB students and that policy effects replicate in untreated states. A brief discussion noting potential limits—e.g., that the effects may vary in more rural or conservative states—will make the policy implications more nuanced.

- **Ensure the robustness appendix is accessible.** Some robustness analyses (placebo outcomes, leave-one-out) could benefit from more detailed tables or figures showing coefficient distributions. This would let readers assess whether the results depend disproportionately on one outcome or state.

These suggestions aim to enhance transparency, fortify identification, and make the policy message more precise, without requiring entirely new data collection.
